Literature DB >> 22215009

Application of a mouse ligated Peyer’s patch intestinal loop assay to evaluate bacterial uptake by M cells.

Shinji Fukuda1, Koji Hase, Hiroshi Ohno.   

Abstract

The inside of our gut is inhabited with enormous number of commensal bacteria. The mucosal surface of the gastrointestinal tract is continuously exposed to them and occasionally to pathogens. The gut-associated lymphoid tissue (GALT) play a key role for induction of the mucosal immune response to these microbes. To initiate the mucosal immune response, the mucosal antigens must be transported from the gut lumen across the epithelial barrier into organized lymphoid follicles such as Peyer's patches. This antigen transcytosis is mediated by specialized epithelial M cells. M cells are atypical epithelial cells that actively phagocytose macromolecules and microbes. Unlike dendritic cells (DCs) and macrophages, which target antigens to lysosomes for degradation, M cells mainly transcytose the internalized antigens. This vigorous macromolecular transcytosis through M cells delivers antigen to the underlying organized lymphoid follicles and is believed to be essential for initiating antigen-specific mucosal immune responses. However, the molecular mechanisms promoting this antigen uptake by M cells are largely unknown. We have previously reported that glycoprotein 2 (Gp2), specifically expressed on the apical plasma membrane of M cells among enterocytes, serves as a transcytotic receptor for a subset of commensal and pathogenic enterobacteria, including Escherichia coli and Salmonella enterica serovar Typhimurium (S. Typhimurium), by recognizing FimH, a component of type I pili on the bacterial outer membrane. Here, we present a method for the application of a mouse Peyer's patch intestinal loop assay to evaluate bacterial uptake by M cells. This method is an improved version of the mouse intestinal loop assay previously described. The improved points are as follows: 1. Isoflurane was used as an anesthetic agent. 2. Approximately 1 cm ligated intestinal loop including Peyer's patch was set up. 3. Bacteria taken up by M cells were fluorescently labeled by fluorescence labeling reagent or by overexpressing fluorescent protein such as green fluorescent protein (GFP). 4. M cells in the follicle-associated epithelium covering Peyer's patch were detected by whole-mount immunostainig with anti Gp2 antibody. 5. Fluorescent bacterial transcytosis by M cells were observed by confocal microscopic analysis. The mouse Peyer's patch intestinal loop assay could supply the answer what kind of commensal or pathogenic bacteria transcytosed by M cells, and may lead us to understand the molecular mechanism of how to stimulate mucosal immune system through M cells.

Entities:  

Mesh:

Year:  2011        PMID: 22215009      PMCID: PMC3369658          DOI: 10.3791/3225

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  11 in total

Review 1.  Intestinal IgA synthesis: regulation of front-line body defences.

Authors:  Sidonia Fagarasan; Tasuku Honjo
Journal:  Nat Rev Immunol       Date:  2003-01       Impact factor: 53.106

2.  M cell transport of Vibrio cholerae from the intestinal lumen into Peyer's patches: a mechanism for antigen sampling and for microbial transepithelial migration.

Authors:  R L Owen; N F Pierce; R T Apple; W C Cray
Journal:  J Infect Dis       Date:  1986-06       Impact factor: 5.226

3.  Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles.

Authors:  R L Owen; A L Jones
Journal:  Gastroenterology       Date:  1974-02       Impact factor: 22.682

4.  Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses.

Authors:  Siegfried Hapfelmeier; Melissa A E Lawson; Emma Slack; Jorum K Kirundi; Maaike Stoel; Mathias Heikenwalder; Julia Cahenzli; Yuliya Velykoredko; Maria L Balmer; Kathrin Endt; Markus B Geuking; Roy Curtiss; Kathy D McCoy; Andrew J Macpherson
Journal:  Science       Date:  2010-06-25       Impact factor: 47.728

5.  Enteropathogenicity of Escherichia coli. I. Evaluation of mouse intestinal loops.

Authors:  K Punyashthiti; R A Finkelstein
Journal:  Infect Immun       Date:  1971-10       Impact factor: 3.441

6.  Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response.

Authors:  Koji Hase; Kazuya Kawano; Tomonori Nochi; Gemilson Soares Pontes; Shinji Fukuda; Masashi Ebisawa; Kazunori Kadokura; Toru Tobe; Yumiko Fujimura; Sayaka Kawano; Atsuko Yabashi; Satoshi Waguri; Gaku Nakato; Shunsuke Kimura; Takaya Murakami; Mitsutoshi Iimura; Kimiyo Hamura; Shin-Ichi Fukuoka; Anson W Lowe; Kikuji Itoh; Hiroshi Kiyono; Hiroshi Ohno
Journal:  Nature       Date:  2009-11-12       Impact factor: 49.962

7.  Role of Peyer's patches in the induction of Helicobacter pylori-induced gastritis.

Authors:  Shigenori Nagai; Hitomi Mimuro; Taketo Yamada; Yukiko Baba; Kazuyo Moro; Tomonori Nochi; Hiroshi Kiyono; Toshihiko Suzuki; Chihiro Sasakawa; Shigeo Koyasu
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-14       Impact factor: 11.205

8.  Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches.

Authors:  V B Jensen; J T Harty; B D Jones
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

9.  M-cell surface beta1 integrin expression and invasin-mediated targeting of Yersinia pseudotuberculosis to mouse Peyer's patch M cells.

Authors:  M A Clark; B H Hirst; M A Jepson
Journal:  Infect Immun       Date:  1998-03       Impact factor: 3.441

10.  M cells--entryways of opportunity for enteropathogens.

Authors:  R L Owen
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

View more
  7 in total

Review 1.  The dormant blood microbiome in chronic, inflammatory diseases.

Authors:  Marnie Potgieter; Janette Bester; Douglas B Kell; Etheresia Pretorius
Journal:  FEMS Microbiol Rev       Date:  2015-05-03       Impact factor: 16.408

2.  Isolating and immunostaining lymphocytes and dendritic cells from murine Peyer's patches.

Authors:  Magdia De Jesus; Sarita Ahlawat; Nicholas J Mantis
Journal:  J Vis Exp       Date:  2013-03-17       Impact factor: 1.355

3.  Mucosal immunity-mediated modulation of the gut microbiome by oral delivery of probiotics into Peyer's patches.

Authors:  Sisi Lin; Subhajit Mukherjee; Juanjuan Li; Weiliang Hou; Chao Pan; Jinyao Liu
Journal:  Sci Adv       Date:  2021-05-12       Impact factor: 14.136

4.  Activated Peyer's patch B cells sample antigen directly from M cells in the subepithelial dome.

Authors:  Rathan Joy Komban; Anneli Strömberg; Adi Biram; Jakob Cervin; Cristina Lebrero-Fernández; Neil Mabbott; Ulf Yrlid; Ziv Shulman; Mats Bemark; Nils Lycke
Journal:  Nat Commun       Date:  2019-06-03       Impact factor: 14.919

5.  Intestinal Epithelium-Derived Luminally Released Extracellular Vesicles in Sepsis Exhibit the Ability to Suppress TNF-a and IL-17A Expression in Mucosal Inflammation.

Authors:  Michael G Appiah; Eun Jeong Park; Samuel Darkwah; Eiji Kawamoto; Yuichi Akama; Arong Gaowa; Manisha Kalsan; Shandar Ahmad; Motomu Shimaoka
Journal:  Int J Mol Sci       Date:  2020-11-10       Impact factor: 5.923

6.  Pancreatic glycoprotein 2 is a first line of defense for mucosal protection in intestinal inflammation.

Authors:  Yosuke Kurashima; Takaaki Kigoshi; Sayuri Murasaki; Fujimi Arai; Kaoru Shimada; Natsumi Seki; Yun-Gi Kim; Koji Hase; Hiroshi Ohno; Kazuya Kawano; Hiroshi Ashida; Toshihiko Suzuki; Masako Morimoto; Yukari Saito; Ai Sasou; Yuki Goda; Yoshikazu Yuki; Yutaka Inagaki; Hideki Iijima; Wataru Suda; Masahira Hattori; Hiroshi Kiyono
Journal:  Nat Commun       Date:  2021-02-16       Impact factor: 14.919

7.  Deep-fried oil consumption in rats impairs glycerolipid metabolism, gut histology and microbiota structure.

Authors:  Zhongkai Zhou; Yuyang Wang; Yumei Jiang; Yongjia Diao; Padraig Strappe; Paul Prenzler; Jamie Ayton; Chris Blanchard
Journal:  Lipids Health Dis       Date:  2016-04-28       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.